| 标题 |
Nivolumab, Pomalidomide, and Elotuzumab Combination Regimens for Treatment of Relapsed and Refractory Multiple Myeloma: Results from the Phase 3 CheckMate 602 Study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Clinical Lymphoma, Myeloma & Leukemia 作者:Albert Oriol; Roman Hájek; Ivan Špıčka; Irwindeep Sandhu; Yaël C. Cohen; et al 出版日期:2024-05-19 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)